Literature DB >> 10573005

A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.

M Tassabehji1, M Carette, C Wilmot, D Donnai, A P Read, K Metcalfe.   

Abstract

Williams-Beuren syndrome (WS) is a developmental disorder caused by a hemizygous microdeletion of approximately 1.4MB at chromosomal location 7q11.23. The transcription map of the WS critical region is not yet complete. We have isolated and characterised a 3.4 kb gene, GTF3, which occupies about 140 kb of the deleted region. Northern blot analysis showed that the gene is expressed in skeletal muscle and heart, and RT-PCR analysis showed expression in a range of adult tissues with stronger expression in foetal tissues. Part of the conceptual GTF3 protein sequence is almost identical to a recently reported slow muscle-fibre enhancer binding protein MusTRD1, and shows significant homology to the 90 amino-acid putative helix-loop-helix repeat (HLH) domains of the transcription factor TFII-I (encoded for by the gene GTF2I). These genes may be members of a new family of transcription factors containing this HLH-like repeated motif. Both GTF3 and GTF2I map within the WS deleted region, with GTF2I being positioned distal to GTF3. GTF3 is deleted in patients with classic WS, but not in patients we have studied with partial deletions of the WS critical region who have only supravalvular aortic stenosis. A feature of WS is abnormal muscle fatiguability, and we suggest that haploinsufficiency of the GTF3 gene may be the cause of this.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573005     DOI: 10.1038/sj.ejhg.5200396

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  13 in total

1.  Generation and comparative analysis of approximately 3.3 Mb of mouse genomic sequence orthologous to the region of human chromosome 7q11.23 implicated in Williams syndrome.

Authors:  Udaya DeSilva; Laura Elnitski; Jacquelyn R Idol; Johannah L Doyle; Weiniu Gan; James W Thomas; Scott Schwartz; Nicole L Dietrich; Stephen M Beckstrom-Sternberg; Jennifer C McDowell; Robert W Blakesley; Gerard G Bouffard; Pamela J Thomas; Jeffrey W Touchman; Webb Miller; Eric D Green
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

2.  Molecular dissection of DNA sequences and factors involved in slow muscle-specific transcription.

Authors:  S Calvo; D Vullhorst; P Venepally; J Cheng; I Karavanova; A Buonanno
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.

Authors:  Paulina Carmona-Mora; Jocelyn Widagdo; Florence Tomasetig; Cesar P Canales; Yeojoon Cha; Wei Lee; Abdullah Alshawaf; Mirella Dottori; Renee M Whan; Edna C Hardeman; Stephen J Palmer
Journal:  Hum Genet       Date:  2015-08-15       Impact factor: 4.132

4.  Repression of TFII-I-dependent transcription by nuclear exclusion.

Authors:  M I Tussié-Luna; D Bayarsaihan; F H Ruddle; A L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

5.  An atypical 7q11.23 deletion in a normal IQ Williams-Beuren syndrome patient.

Authors:  Giovanni Battista Ferrero; Cédric Howald; Lucia Micale; Elisa Biamino; Bartolomeo Augello; Carmela Fusco; Maria Giuseppina Turturo; Serena Forzano; Alexandre Reymond; Giuseppe Merla
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

6.  MEF2 transcription factors regulate distinct gene programs in mammalian skeletal muscle differentiation.

Authors:  Nelsa L Estrella; Cody A Desjardins; Sarah E Nocco; Amanda L Clark; Yevgeniy Maksimenko; Francisco J Naya
Journal:  J Biol Chem       Date:  2014-11-21       Impact factor: 5.157

7.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta.

Authors:  María Isabel Tussié-Luna; Dashzeveg Bayarsaihan; Edward Seto; Frank H Ruddle; Ananda L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

8.  GTF2IRD2 is located in the Williams-Beuren syndrome critical region 7q11.23 and encodes a protein with two TFII-I-like helix-loop-helix repeats.

Authors:  Aleksandr V Makeyev; Lkhamsuren Erdenechimeg; Ognoon Mungunsukh; Jutta J Roth; Badam Enkhmandakh; Frank H Ruddle; Dashzeveg Bayarsaihan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

9.  Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity.

Authors:  Enoch S E Tay; Kim L Guven; Nanthakumar Subramaniam; Patsie Polly; Laura L Issa; Peter W Gunning; Edna C Hardeman
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

10.  Alternative splicing and promoter use in TFII-I genes.

Authors:  Aleksandr V Makeyev; Dashzeveg Bayarsaihan
Journal:  Gene       Date:  2008-12-09       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.